“Sumner’s diverse experience across healthcare investment banking and investing makes him uniquely positioned to lead our Biopharma effort,” said John Hudson, Managing Director and head of Consumer, Healthcare and Gaming Investment Banking. “Sumner will be a strong addition to our team, helping to drive financing and strategic solutions tailored to our clients’ needs.”
Anderson has more than 12 years of industry experience. Prior to joining Wells Fargo, he was the Global Equities Pharmaceutical Analyst at Citadel Investment Group LLC in Chicago where he covered U.S. and European pharmaceutical companies. He began his career in investment banking at Salomon Smith Barney and Thomas Weisel Partners after serving as an officer in the United States Navy. Anderson holds a B.A. degree with honors in History and Economics from Harvard University and an M.B.A. from New York University where he was a Stern Scholar.
Wells Fargo & Company is a diversified financial services company with $1.3 trillion in assets, providing banking, insurance, investments, mortgage and consumer finance through more than 10,000 stores and 12,000 ATMs and the internet (wellsfargo.com) across North America and internationally.
Wells Fargo Securities is the trade name for certain capital markets and investment banking services of Wells Fargo & Company and its subsidiaries, including Wells Fargo Securities, LLC, member FINRA and SIPC, and Wachovia Bank, National Association.